Bill creating virology, vaccine institute passed | Inquirer

ATTACHED TO DOST

Bill creating virology, vaccine institute passed

By: - Reporter /
/ 05:00 AM December 06, 2022

The House of Representatives on Monday approved on third and final reading a measure setting up the Virology and Vaccine Institute of the Philippines (VIP).

House Bill No. 6452 or the VIP Act was approved following the affirmative votes by 216 lawmakers at the plenary and a report was transmitted to the Senate.

The VIP under HB 6452 would primarily conduct research on viruses and other pathogens; develop diagnostics, vaccines and treatment for viruses and other pathogens; establish international cooperation and network of databases of virus infections; operate a virology laboratory, virus gene bank and virus genome laboratory; and operate a virus high-containment laboratory dedicated to the study of highly infectious and highly pathogenic viruses.

Article continues after this advertisement

The institute would be an attached agency of the Department of Science and Technology “for purposes of policy and progress coordination to ensure alignment in national policies and priorities.”

FEATURED STORIES

The VIP would serve as the “premier research and development institute in the field of virology, encompassing all kinds of viruses and viral diseases in plants, animals, and humans.

It shall also be a venue for scientists, research institutes and other organizations in the Philippines and abroad to work collaboratively to study viruses of agricultural, industrial, clinical and environmental importance.” INQ

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

MOST READ
www
entertainment
www
entertainment
entertainment
TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.